Cargando…

Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography

INTRODUCTION: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a secretory protein that activates corin in the heart. Higher circulating levels of corin are associated with improved cardiovascular outcomes in patients with acute myocardial infarction. This study aimed to determine the role of ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shang-Feng, Chou, Ruey-Hsing, Lin, Shing-Jong, Li, Szu-Yuan, Huang, Po-Hsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905542/
https://www.ncbi.nlm.nih.gov/pubmed/31825978
http://dx.doi.org/10.1371/journal.pone.0226129
_version_ 1783478181750112256
author Yang, Shang-Feng
Chou, Ruey-Hsing
Lin, Shing-Jong
Li, Szu-Yuan
Huang, Po-Hsun
author_facet Yang, Shang-Feng
Chou, Ruey-Hsing
Lin, Shing-Jong
Li, Szu-Yuan
Huang, Po-Hsun
author_sort Yang, Shang-Feng
collection PubMed
description INTRODUCTION: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a secretory protein that activates corin in the heart. Higher circulating levels of corin are associated with improved cardiovascular outcomes in patients with acute myocardial infarction. This study aimed to determine the role of serum PCSK6 and corin levels in predicting cardiovascular outcomes in patients with suspected coronary artery disease (CAD). MATERIALS AND METHODS: In total, 565 patients who had undergone coronary angiography were enrolled. Serum PCSK6 and corin levels were determined before the administration of contrast media. In this study, coronary revascularization, acute myocardial infarction, acute stroke, and death were defined as cardiovascular outcomes. All patients were followed up for at least one year after coronary angiography or until the occurrence of death. RESULTS: During a median follow-up of 691 days, 67 patients (15.7%) developed composite cardiovascular outcomes after coronary angiography, including 51 incidents of coronary revascularization, 7 instances of acute myocardial infarction, 2 acute strokes, and 15 deaths. After adjustment for demographic characteristics and all significant variables in the univariate analysis, serum levels of neither PCSK6 nor corin were associated with increased risk for cardiovascular outcomes. This correlation remained insignificant in patients with underlying hypertension, diabetes mellitus, CAD, heart failure, or chronic kidney disease (CKD). However, in patients without CKD, higher serum PCSK6 levels were associated with increased risk for cardiovascular outcomes (hazard ratio 1.380; 95% confidence interval 1.023–1.862). CONCLUSIONS: We found no association between cardiovascular outcomes and pre-procedural serum levels of PCSK6 or corin in patients undergoing coronary angiography. However, an increased risk was seen in non-CKD patients with higher PCSK6 levels. Further studies are needed to verify these results.
format Online
Article
Text
id pubmed-6905542
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69055422019-12-27 Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography Yang, Shang-Feng Chou, Ruey-Hsing Lin, Shing-Jong Li, Szu-Yuan Huang, Po-Hsun PLoS One Research Article INTRODUCTION: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a secretory protein that activates corin in the heart. Higher circulating levels of corin are associated with improved cardiovascular outcomes in patients with acute myocardial infarction. This study aimed to determine the role of serum PCSK6 and corin levels in predicting cardiovascular outcomes in patients with suspected coronary artery disease (CAD). MATERIALS AND METHODS: In total, 565 patients who had undergone coronary angiography were enrolled. Serum PCSK6 and corin levels were determined before the administration of contrast media. In this study, coronary revascularization, acute myocardial infarction, acute stroke, and death were defined as cardiovascular outcomes. All patients were followed up for at least one year after coronary angiography or until the occurrence of death. RESULTS: During a median follow-up of 691 days, 67 patients (15.7%) developed composite cardiovascular outcomes after coronary angiography, including 51 incidents of coronary revascularization, 7 instances of acute myocardial infarction, 2 acute strokes, and 15 deaths. After adjustment for demographic characteristics and all significant variables in the univariate analysis, serum levels of neither PCSK6 nor corin were associated with increased risk for cardiovascular outcomes. This correlation remained insignificant in patients with underlying hypertension, diabetes mellitus, CAD, heart failure, or chronic kidney disease (CKD). However, in patients without CKD, higher serum PCSK6 levels were associated with increased risk for cardiovascular outcomes (hazard ratio 1.380; 95% confidence interval 1.023–1.862). CONCLUSIONS: We found no association between cardiovascular outcomes and pre-procedural serum levels of PCSK6 or corin in patients undergoing coronary angiography. However, an increased risk was seen in non-CKD patients with higher PCSK6 levels. Further studies are needed to verify these results. Public Library of Science 2019-12-11 /pmc/articles/PMC6905542/ /pubmed/31825978 http://dx.doi.org/10.1371/journal.pone.0226129 Text en © 2019 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Yang, Shang-Feng
Chou, Ruey-Hsing
Lin, Shing-Jong
Li, Szu-Yuan
Huang, Po-Hsun
Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography
title Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography
title_full Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography
title_fullStr Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography
title_full_unstemmed Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography
title_short Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography
title_sort serum pcsk6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905542/
https://www.ncbi.nlm.nih.gov/pubmed/31825978
http://dx.doi.org/10.1371/journal.pone.0226129
work_keys_str_mv AT yangshangfeng serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography
AT chourueyhsing serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography
AT linshingjong serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography
AT liszuyuan serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography
AT huangpohsun serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography